市場調査レポート
商品コード
1439892
特殊PACS - 世界市場の考察、競合情勢、市場予測(2030年)Specialty PACS - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
特殊PACS - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の特殊PACSの市場規模は、2023年に28億1,532万米ドル、2030年までに43億392万米ドルに達し、2024年~2030年の予測期間にCAGRで7.45%の成長が見込まれます。市場は、世界中での乳がん罹患率の増加、心血管疾患の罹患率の上昇、老年人口の罹患率の上昇、市場における特殊PACS製品の発売の急増などのさまざまな要因によってプラス成長を示しています。したがって、市場は2024年~2030年の予測期間に成長すると推定されます。
特殊PACSの市場力学
特殊PACS市場の主な促進要因の1つは、世界中での乳がんの有病率の増加です。例えば、世界保健機関(WHO)が2023年に発表したデータによると、2020年に世界中で約230万人の女性が乳がんと診断されました。上記の資料と統計によれば、世界中で過去5年間に780万人の女性が乳がんと診断されたことになります。このように、特殊PACSは乳房イメージングソリューションとして機能し、患者の全体像を把握し、マンモグラムなどの放射線画像の読影を可能にします。したがって、乳がんの有病率の増加は、特殊PACSの需要を増加させ、予測期間(2024年~2030年)に特殊PACS市場全体を前進させます。
さらに、特殊PACS市場の成長をもたらすもう1つの主な要因が、心血管疾患の罹患率の上昇です。例えば、British Heart Foundationが2023年に発表した最新データによると、2019年、アジアでは3,237万6,834人が心血管疾患と診断され、1,254万3,833人が冠動脈疾患に罹患し、811万1,044人が脳卒中と確認されました。このように、循環器科におけるPACSは、循環器専門医や技師が入院患者の治療に対応する際に使用できる画像情報を提供します。したがって、心血管疾患の罹患率の増加は、特殊PACSの需要を向上させ、ひいては特殊PACSの市場全体に成長しやすい環境を提供する可能性があります。
さらに、上記の要因によってPACSの需要が増加し、2024年~2030年の予測期間に特殊PACS市場全体の成長を急加速させる可能性があります。
しかし、特殊PACSシステムの高いコストや、データセキュリティとプライバシーの問題など、外科手術に関連する複雑な問題が、世界の特殊PACS市場の成長を妨げる可能性があります。
さらに、進行中のCOVID-19パンデミックは、特殊PACS市場に大きな影響を与えています。ほぼすべての国で全国的なロックダウンが行われ、移動制限がCOVID-19患者以外の病院訪問数を減少させ、生産現場における労働力の利用不能が特殊PACS製品の製造率を妨げました。しかし、COVID-19時代には、ウイルスに罹患した患者の身体の画像を保存し、簡単にアクセスするために特殊PACSを使用することができました。さらに、多くの人々が予防接種を受け、患者の入院制限や通院制限が緩和され、サプライチェーン、ロジスティクス、製造施設が再開されたことで、特殊PACSは予測期間にさらなる成長が見込まれます。
特殊PACS市場のセグメント分析
特殊PACS市場のタイプセグメントでは、放射線PACSが2023年に大きな収益シェアを占めると予測されています。市場の成長を促進する主な特徴は、放射線データを転送、保存するだけでなく、非常に組織化された迅速な方法で表示することができ、より正確な結果をもたらすことなどです。また、高品質な画像を提供し、画像をデジタル操作することもできます。
さらに、放射線PACSに関連する主な利点が特殊PACSの需要を増加させ、予測期間に世界の特殊PACS市場全体の成長を促進する可能性があります。また一方で、特殊PACSに関連するパートナーシップの増加も、市場の成長促進要因となっています。
当レポートでは、世界の特殊PACS市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Specialty PACS Market By Type (Radiology PACS, Cardiology PACS, And Others), By Application (Breast Imaging, Orthopedic Imaging, Cardiac Imaging, Radiologic Imaging, And Others), By Development (Web-Based Pacs And Cloud-Based), By End-User (Hospitals, Imaging Centers, And Teleradiology Organizations), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising incidence of cardiovascular diseases and increasing prevalence of breast cancer
The global Specialty Picture Archiving and Communication System (PACS) market was valued at USD 2815.32 million in 2023, growing at a CAGR of 7.45% during the forecast period from 2024 to 2030 to reach USD 4303.92 million by 2030. The specialty PACS market is witnessing a positive growth owing to various factors such as the increasing prevalence of breast cancer globally, rising incidence of cardiovascular diseases, rising prevalence of geriatric population and surge in the specialty PACS products launch in the market. Therefore, the market for specialty PACS is estimated to grow during the forecast period from 2024 to 2030.
Specialty PACS Market Dynamics:
One of the main drivers of the specialty PACS market is the increasing prevalence of breast cancer globally. For instance, according to the World Health Organization (WHO) published data in the year 2023, in 2020, approximately 2.3 million women were diagnosed with breast cancer worldwide. As per the above referenced source and statistics, around the world, 7.8 million women would have been diagnosed with breast cancer in the previous five years. Thus, specialty PACS act as a breast imaging solution, it gives the full patient overview and allows to read radiology images such as mammograms. Therefore, increasing the prevalence of breast cancer, increases the specialty PACS demand, thereby propelling the specialty PACS overall market forward over the forecast period (2024-2030).
Moreover, another key factor which is responsible for the growth of specialty PACS market is the rising incidence of cardiovascular diseases. For instance, according to the latest data published by the British Heart Foundation in the year 2023, in 2019, in Asia, 32,376,834 people were diagnosed with cardiovascular diseases, 12,543,833 individuals were affected with coronary artery disease, and 8,111,044 population was identified with stroke. Thus, PACS in cardiology provides imaging information which can be used by cardiologists and technicians while dealing with the inpatient care. Therefore, rising incidence of cardiovascular diseases, would uplift the demand of specialty PACS which in turn can provide a conductive growth environment for the specialty PACS overall market.
Furthermore, due to the factors mentioned above, the PACS demand will increase, which could surge the growth of the overall specialty PACS market during the forecast period from 2024 to 2030.
However, high cost of specialty PACS systems and complications related to surgical procedures such as data security & privacy issues, this can hamper the global specialty PACS market growth.
Additionally, the ongoing COVID-19 pandemic has significantly impacted the specialty PACS market. There was a nationwide lockdown in almost every country, movement restrictions declined the number of hospital visits other than COVID-19 patients and unavailability of the workforce at the production sites hampered the manufacturing rate of specialty PACS products. However, during the COVID-19 era specialty PACS could have been used to store and access images easily of patients body those who were suffering with the virus. Furthermore, with the masses being vaccinated, relaxation in the lockdown restrictions & the hospital visits of patients as well as resumption of supply chains, logistics, and manufacturing units, the specialty PACS can be expected to further grow during the forecast period.
Specialty PACS Market Segment Analysis:
Specialty PACS Market by Type (Radiology PACS, Cardiology PACS, and Others), Application (Breast Imaging, Orthopedic Imaging, Cardiac Imaging, Radiologic Imaging, and Others), Development (Web-Based and Cloud-Based), End-User (Hospitals, Imaging Centers, and Teleradiology Organizations), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the by-type segment of the specialty PACS market, radiology PACS is expected to hold a significant revenue share in the year 2023. The key attributes driving the growth of the specialty PACS market includes, that it allows radiology data to be transferred, stored, as well as viewed in a much organized and quick manner, resulting in more accurate outcomes. It also provides quality images and the ability to digitally manipulate the images.
Furthermore, the key benefits associated with radiology PACS would increase the demand for specialty PACS, which could drive the growth of the overall global specialty PACS market during the forecast period. However, an increasing number of partnerships associated with the specialty PACS also drives the market growth.
Also, in December 2022, Synapsica, an AI radiology reporting company announced the partnership with GenWorks Health, a healthcare solution provider backed by Wipro GE Healthcare, to bring its Picture Archiving and Communication System (PACS) to more cities across India. Its Radiolens radiology workflow solution automatically identifies poor quality scans and generates preliminary reports for most common modalities. Additionally, it offers both quantitative and qualitative actionable insights powered by Artificial Intelligence (AI). Through this partnership, the product will become accessible in over 300 tier 2 & 3 cities and towns, such as Maharashtra, Andhra Pradesh, West Bengal, and Chennai. The system has cleared both the United States and the European approval.
Furthermore, such type of activities and benefits associated with radiology PACS, in the type segment would result in the rising demand for specialty PACS which in turn would provide a conducive growth for the overall specialty PACS market during the forecast 2024-2030.
North America is expected to dominate the overall Specialty PACS Market:
Among all the regions, North America is expected to dominate the global specialty PACS market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. Factors such as the increasing prevalence of cardiovascular diseases and the surge in the specialty PACS products launch in the market are expected to increase the demand for specialty PACS in the North American market.
According to the latest data published by the British Heart Foundation in the year 2023, in 2019, in North America, the cardiovascular diseases affected 4,103,135 people, 1,089,947 people were diagnosed with coronary artery disease, and 498,551 had suffered from stroke. Thus, PACS in cardiology provides imaging information which can be used by cardiologists and technicians while dealing with the inpatient care. Therefore, rising incidence of cardiovascular diseases, can elevate the demand of specialty PACS, which would drive the overall specialty PACS market forward over the forecast period (2024-2030).
Furthermore, another factor that is responsible for the growth of specialty PACS market is the surge in the specialty PACS products launch in the market. For instance, in April 2020, Konica Minolta Healthcare Americas, a leader in medical diagnostics, released its Rede PACS, the company's most recent medical image management solution for specialized clinics, as well as Rede Mini PACS for managing ultrasound and X-ray images are now offered for sale in the US.
Therefore, due to interplay of the factors mentioned above, there will be high demand for specialty PACS, which would provide a conductive growth environment for the North American region in the specialty PACS market.
Specialty PACS Market Key Players:
Some of the key market players operating in the Specialty PACS market include Novarad, IBM, Koninklijke Philips N.V, INFINITT Healthcare Co Ltd, FUJIFILM Holdings America Corporation, General Electric Company, PaxeraHealth, Siemens Medical Solutions USA Inc, Sectra AB, Topcon Corporation, Carestream Health, Intelerad Medical Systems Incorporated, Agfa-Gevaert Group, Hyland Software Inc, Mach7 Technologies, Amrita Technologies, Medsynaptic Pvt. Ltd, iCRco Inc, Konica Minolta Inc, SinoVision, O3 Enterprise s.r.l, among others
Recent Developmental Activities in the Specialty PACS:
In October 2022, Ambra Health, a pioneer in cloud-based medical image management systems, has been acquired by Intelerad Medical Systems, a world leader in medical image management solutions. The unified platform will offer a superior cloud solution for reading, storing, and distributing diagnostic images to doctors, patients, and for researchers. Ambra adds a strong cloud VNA, image interchange functionality, research, and pathology capabilities to Intelerad's offering in addition to the company's award-winning PACS.
In August 2022, GE Healthcare, a manufacturer & distributor of diagnostic imaging agents as well as radiopharmaceuticals for imaging modalities used in medical imaging procedures, offers Edison True PACS, a diagnostic imaging and workflow solution created to assist radiologists. It is now accessible in the United States.
In November 2022, Change Healthcare, a leading healthcare technology company, announced that Stratus Imaging PACS, a cloud-native, zero-footprint Picture Archiving and Communication System, is live in clinical use. It offers radiology practitioners a seamless way to read pictures from many hospitals on a single platform, whenever they want, from anywhere, even at home and on mobile devices.
Key Takeaways from the Specialty PACS Market Report Study
Target Audience who can be benefited from this Specialty PACS Market Report Study
Frequently Asked Questions for Specialty PACS:
Specialty PACS, a type of medical imaging technology widely utilized in healthcare organizations for the secure digital transmission of clinically important information and electronic pictures.
The global Specialty Picture Archiving and Communication System (PACS) market was valued at USD 2815.32 million in 2023, growing at a CAGR of 7.45% during the forecast period from 2024 to 2030 to reach USD 4303.92 million by 2030.
The specialty PACS market is witnessing a positive market growth owing to the factors such as the increasing prevalence of breast cancer globally, rising incidence of cardiovascular diseases, rising prevalence of geriatric population and surge in the specialty PACS products launch in the market.
Some of the key market players operating in the specialty PACS market include Novarad, IBM, Koninklijke Philips N.V, INFINITT Healthcare Co Ltd, FUJIFILM Holdings America Corporation, General Electric Company, PaxeraHealth, Siemens Medical Solutions USA Inc, Sectra AB, Topcon Corporation, Carestream Health, Intelerad Medical Systems Incorporated, Agfa-Gevaert Group, Hyland Software Inc, Mach7 Technologies, Amrita Technologies, Medsynaptic Pvt. Ltd, iCRco Inc, Konica Minolta Inc, SinoVision, O3 Enterprise s.r.l, and others
North America is expected to dominate the global specialty PACS market. Factors contributing to the growth of specialty PACS market in the North America region are the rising incidence of cardiovascular diseases and surge in the specialty PACS products launch in the market